Eli Lilly's Retatrutide Hits 30% Weight Loss in Pivotal Trial, Redefining Obesity Treatment | Answer

Eli Lilly's Retatrutide Hits 30% Weight Loss in Pivotal Trial, Redefining Obesity Treatment | Answer | Studio Global AI